Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Controlled drug delivery systems are crucial for enhancing therapeutic efficacy and reducing side effects.
• Magnetic nanoparticles offer potential for targeted delivery and remote activation of therapeutic agents.
• Lipid nanoparticles provide biocompatible matrices for drug encapsulation and controlled release.

Purpose of the Study:

• To develop novel magnetic lipid nanoparticles (MLNs) for magnetically controlled drug release.
• To investigate the heating properties of MLNs under an alternating magnetic field.
• To evaluate the drug release kinetics from MLNs triggered by magnetic hyperthermia.

Main Methods:

• Fabrication of MLNs by high-pressure homogenization, incorporating super-paramagnetic gamma-Fe2O3 nanoparticles within a lipid matrix.
• Characterization of MLN size, morphology, and magnetic properties.
• In vitro assessment of MLN heating response to an alternating magnetic field (60 kA/m, 25 kHz) and subsequent drug release.

Main Results:

• MLNs with average sizes between 100 and 180 nm were successfully fabricated.
• Exposure to an alternating magnetic field induced a temperature increase from 37°C to 50°C within 20 minutes.
• Approximately 35% of encapsulated drug molecules were released via diffusion within 20 minutes due to lipid matrix melting.

Conclusions:

• The developed MLNs demonstrate a dual function of magnetic heating and controlled drug release.
• This technology offers a promising platform for enhancing drug delivery performance through externally controlled hyperthermia.
• MLNs represent a novel approach for targeted and triggered therapeutic agent administration.